Albemarle (NYSE: ALB) reported Q2 EPS of $3.45, $0.45 better than the analyst estimate of $3.00. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

Albemarle sees FY2022 EPS of $19.25-$22.25, versus the consensus of $15.87. Albemarle sees FY2022 revenue of $7.1-7.5 billion, versus the consensus of $6.89 billion.

For earnings history and earnings-related data on Albemarle (ALB) click here.